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Evidence independently links smoking, family history, and gender with increased risk of adenomatous polyps. Using data from the
New Hampshire Colonoscopy Registry (2004–2006), we examined the relation of combined risk factors with adenoma occurrence
in 5,395 individuals undergoing screening colonoscopy. Self-reported data on smoking, family history and other factors were
linked to pathology reports identifying adenomatous polyps and modeled with multiple logistic regression. In adjusted models
a >15 pack-year smoking history increased the likelihood of an adenoma (OR = 1.54, 95% CI 1.28–1.86), although ≤15 pack-
years did not (OR = 1.07, 95% CI 0.87–1.32). Gender-stratiﬁed models showed a signiﬁcantly increased risk of adenoma at lower
smoking exposure even for men (OR = 1.32; 95% CI:1.00–1.76), but not for women (OR = 0.85; 95% CI:0.61–1.14). An ordered
logistic regression model of adenoma occurrence showed a smoking history of ≥15 pack-years associated with 61% higher odds
of adenoma at successively larger size categories (95% CI 1.34–1.93). For individuals with a family history of colorectal cancer,
smoking does not further increase the risk of adenomas. Smoking duration is linked to occurrence and size of adenoma, especially
for men.
1.Introduction
Identiﬁcation of risk factors for colonic adenomas is impor-
tant in order to risk stratify individuals for colorectal neo-
plasia and to guide the most appropriate screening recom-
mendations. Many studies have linked age, gender, smoking,
family history, and other factors, with risk of adenoma
occurrence [1–7]. Less well studied are potential modifying
interactions among risk factors. Examining the inﬂuence
of concurrent risk factors on adenomas is important to
clinical practice, since patients often present with multiple
risk factors, which physicians must consider to optimize
individual screening practices. The roles of family history,
smoking, andgenderin adenomadevelopment havereceived
much attention, with signiﬁcant associations demonstrated
for each [5, 7, 8]. Smoking has inconsistently been shown
to be an important risk factor for adenoma occurrence
[3, 5, 6, 8–10] although a recent meta-analysis showed a
signiﬁcant eﬀect [9]. Family history of colorectal cancer or
polyps is known to be associated with a higher likelihood
of developing adenomas, [5, 8]a si sm a l es e x[ 8, 10]. How
these factors, in combination, relate to adenoma risk is not
well characterized. Associations of risk factor combinations
more closely capture clinical presentation of individuals and
should be considered to identify patients at the greatest risk
for neoplastic colonic lesions.
The aim of this study was to test two hypotheses related
to risk of adenomatous polyp occurrence: (1) smoking is
associated with greater incremental risk among individuals
with a relevant family history than those without; (2)
smoking results in greater increase in risk of adenomas
among men than women. We conducted a cross-sectional
study to examine the combined inﬂuences of smoking,
gender, and family history on adenomatous polyp risk in
patients undergoing screening colonoscopy. We character-
ized individuals according to smoking status, gender, and
family history of colorectal cancer or polyps and analyzed
themforsigniﬁcantdiﬀerencesinpersonalpolypoccurrence.2 Journal of Cancer Epidemiology
We also developed logistic regression models to estimate the
likelihood of adenomatous polyps as a function of smoking,
gender, and family history. Our study is important in its
ability to examine the interaction of several important risk
factors which will further inform risk assessment of patients.
2.MaterialsandMethods
2.1. Study Subjects and Data Collection. We used data
from the design phase (2004–2006) of the New Hamp-
shire Colonoscopy Registry (NHCR), including completed
colonoscopies for 7611 individuals, and pathology reports
on 1739 of them. The NHCR is described in detail elsewhere
[11]. Personal data were collected using a patient question-
naire administered prior to the exam, which ascertained
demographic characteristics (age, race, educational level
achieved, marital status, and type of health care coverage),
risk factors (personal and/or family history of colorectal
cancer, polyps, including familial adenomatous polyposis,
hereditary nonpolyposis colon cancer, or other familial poly-
posis, and height and weight), and other health history (use
of aspirin, vitamins and calcium, smoking history, alcohol
use, and exercise routine). A second data collection form
was completed by endoscopists after the colonoscopy and
recorded the indication for the procedure being performed
(screening for no history, or symptoms, screening for family
history, surveillance for patient-related history or diagnostic
exam for symptoms) and all other procedure-related infor-
mation including number and location of polyps removed.
Pathology reports for polyps removed during colonoscopy
examinations were matched to consenting patients. All data
collection and utilization procedures were approved by the
Committee for Protection of Human Subjects at Dartmouth
Medical School.
We included only colonoscopy procedures which were
recorded by the endoscopist as having a screening indication
(including surveillance). We did not include exams with
a diagnostic indication, including evaluation of symptoms.
Exclusion criteria included persons reporting a history of
familial adenomatous polyposis (N = 39), hereditary
nonpolyposis colon cancer (N = 46), ulcerative colitis or
Crohn’s disease (N = 118), or a personal history of polyps
or colorectal cancer (N = 1160). Thus, colonoscopies per-
formed for surveillance rather than screening were excluded.
Also excluded were individuals for whom data collection was
not complete during the study period (sex N = 116, age
N = 317, smoking history N = 50, pathology N = 370).
All patient data, including pathology reports, were linked
by patient identiﬁcation number. Multiple colonoscopies
for individuals were summarized at the patient level using
an algorithm to capture all response variables of interest
over time. Only 72 of the 7683 colonoscopies performed
were for the same individual. In the case of nonconcordant
responses over time, such as change in smoking status, dates
of procedure were linked to pathology reports, and decision
rules were applied. The most frequent response was used,
or the ﬁrst chronologically if frequencies of a given response
were equal.
Table 1:Characteristicsofthestudypopulationundergoingscreen-
ing colonoscopy in the New Hampshire Colonoscopy Registry from
2004–2006.
Total N (%) 5,395
Smoking
No pack-years 2,865 (53)
15 pack-years or fewer 1,243 (23)
More than 15 pack-years 1,287 (24)
Family History
a
Negative 4,649 (86)
Positive 746 (14)
Gender
Male 2,284 (42)
Female 3,111 (58)
Adenoma
None 4,689 (87)
One or more 706 (13)
Adenoma Size
No Adenoma 4,672 (87)
≤5mm 318 (6)
5–9mm 268 (5)
≥1cm 120 (2)
Mean (SO)
Mean Age (yrs.) 56 (±11)
aFamilyhistorywasdeﬁnedasareporteddiagnosisofcolonorrectalcancer
in a mother, father, sibling, or child of the patient.
Table 2: Self-reported smoking history among men and women
with colonoscopy in the New Hampshire Colonoscopy Registry
from 2004–2006.
Smoking History
No Pack-Years ≤15 Pack-Years >15 Pack-Years
Men 1135 (50) 492 (21) 658 (29)
Women 1730 (56) 751 (24) 630 (20)
2.2. Key Variable Deﬁnition. Smoking exposure was deﬁned
by pack-years: none, 15 or fewer, more than 15. Family
history was deﬁned as a reported diagnosis of colon or
rectal cancer in one or more ﬁrst degree relatives (mother,
father, sibling, or child of the patient). Polyps classiﬁed
as adenomas included tubular adenoma, tubular-villous
adenoma, villous adenoma, or mixed polyps. Concurrent
adenomatous and hyperplastic polyps were identiﬁed by
having polyp specimens with each histological classiﬁcation
during the study period. Pathology reports indicating a
mixed polyp were classiﬁed as a single polyp at the highest
grade reported. We included health history and behavioral
variables which are thought to be risk factors or risk
modiﬁers for polyp occurrence, speciﬁcally: aspirin use [7],
alcohol consumption [5, 7, 10], exercise [5, 7], vitamin
use [5], supplemental calcium [5, 10], and family history
of colorectal cancer or polyps [7, 8]. To maintain robust
analyses in regard to sample size, we classiﬁed use of aspirin,
vitamins, calcium supplementation, and exercise on a binaryJournal of Cancer Epidemiology 3
Table 3
(a) Comparison of adenoma occurrence among men and women in a colorectal screening population in relation to smoking history.
Men (N, column%) Women (N, column %)
Adenoma Status No Pack-Years ≤15 Pack-Years >15 Pack-Years Pa No Pack-Years ≤15 Pack-Years >15 Pack-Years Pa
None 969 (85) 402 (82) 514 (78) <. 001 1,570 (91) 693 (92) 541 (86) <. 001
One or more 166 (15) 90 (18) 143 (22) 160 (9) 58 (8) 89 (14)
(b) Comparisonofadenomasamongacolorectalscreeningpopulationwithandwithoutafamilyhistoryofcolorectalcancerorpolyps,inrelationtosmoking
status.
No Family History Family History
Adenoma Status No Pack-Years ≤15 Pack-Years >15 Pack-Years Pa No Pack-Years ≤15 Pack-Years >15 Pack-Years Pa
None 2,195 (90) 935 (88) 944 (83) <. 001 344 (83) 160 (86) 111 (75) .019
One or more 257 (10) 123 (12) 195 (17) 69 (17) 25 (14) 37 (25)
aP-values based on Pearson’s χ2.
scale (either < or ≥ one time/week). Alcohol consumption
was categorized as follows: none, 1–8 drinks/week, ≥9
drinks/week.
2.3. Analysis. Smokers and nonsmokers were stratiﬁed by
gender and family history separately, and evaluated for
signiﬁcant diﬀerences in adenoma occurrence with Pearson’s
χ2. Univariate logistic regressions were performed for each
exposure and likelihood of adenoma. We developed a mul-
tivariate logistic model of adenoma occurrence, adjusting
for important covariates. We stratiﬁed by gender and by
family history and performed multivariate logistic regression
to evaluate the signiﬁcance of smoking for these stratiﬁed
groups in relation to risk of adenoma. We also formally
tested for interaction of family history with smoking and
of sex with smoking by creating an interaction term based
on a dichotomous smoking response (ever versus never)
and testing in the models using a likelihood ratio test.
Ordered logistic regression models were used to test the
eﬀect of smoking on size of adenoma, with size categories:
no adenoma, <5mm, 5–9mm, and ≥1cm, as the ordered
dependent outcomes. Smoking was evaluated as both a
dichotomous (ever/never) and categorical (pack years: none,
≤15, >15) predictor variable in ordered logistic regression
models. We tested the proportionality of odds assumption
using a likelihood ratio test to conﬁrm the validity of
the ordinal logistic regression model. The models were
adjustedforsigniﬁcantcovariates.Interactiontermswerenot
included in the ordinal logistic models because of the three-
category smoking exposure. All analyses were performed
using Stata 10.0 for Windows (Stata Corp., College Station,
TX) statistical software.
3. Results
A total of 5,395 individuals undergoing screening
colonoscopy were included in the analyses. Characteristics of
the study population based on smoking status are presented
in Table 1. Nonsmokers comprised just over half of the study
population. The smokers were equally represented by those
with 15 or fewer pack-years and those with more than 15
pack-years, although men had greater smoking history than
women (Table 2). Approximately 14% of study subjects
reported a family history of colorectal cancer. More women
than men were in the study population (58% versus 42%)
(Table 1).
Diﬀerences in adenoma occurrence between men and
women with regard to smoking status showed similar
patterns (Table 3(a)). For men and women, smokers with
greater than a 15 pack-year history had a signiﬁcantly
higher proportion of adenomas compared to nonsmokers.
Regardless of smoking status, men had a higher proportion
of adenomas than women.
We also examined the inﬂuence of smoking in those
individuals with and without a family history (Table 3(b)).
When considering patients with no family history, smokers
with>15 pack-years had a signiﬁcantly greater proportion of
adenomas compared to nonsmokers (smokers: 17% versus
nonsmokers: 10%, P<. 001). The same additive eﬀect
was seen among patients with a family history, although
withhigherproportionsofadenomaoccurrence(25%versus
17%, Table 3(b)).
To examine how the key risk factors, gender and family
history might modify the inﬂuence of smoking on adenoma
occurrence, we developed stratiﬁed logistic regression mod-
els (Table 4). Stratifying by gender and adjusting for age
and family history, we found that a 15- or fewer pack-
year smoking history was associated with a 32% increased
likelihood of adenoma compared with nonsmokers among
men (OR = 1.32; 95% CI 1.00–1.76). The odds of adenoma
among male smokers with more than 15 pack-years of
exposure were 55% higher than nonsmokers (OR = 1.55;
95% CI 1.21–2.00). There was no signiﬁcant increase in
adenomas among female smokers in the lowest pack-year
g r o u pc o m p a r e dt on o n s m o k e r s( O R= 1.85; 95% CI 0.61–
1.14). Women with more than 15 pack-years of smoking had
a 55% increased odds of adenoma compared to nonsmokers
(OR = 1.55; 95% CI 1.17–2.05). The likelihood ratio test for
interaction of gender with a dichotomous smoking response
was not signiﬁcant.4 Journal of Cancer Epidemiology
Table 4: Stratiﬁed logistic regression models of smoking and
adenoma occurrence among individuals undergoing screening
colonoscopy in the New Hampshire colonscopy Registry from
2004–2006.
Adenoma v. No Adenoma
Model Odds Ratio (95% Cl)
a
Full Model (n = 5,395)
Smoking
No pack-years 1.00 (referent)
15 pack-years or fewer 1.07 (0.87–1.32)
More than 15 pack-years 1.54 (1.28–1.86)
‡
Sex
Men 1.00 (referent)
Women 0.53 (0.45–0.62)
‡
Family History
b
Negative 1.00 (referent)
Positive 1.73 (1.40–2.15)
‡
Stratiﬁed by Sex
Male (n = 2,284)
No pack-years 1.00 (referent)
15 pack-years or fewer 1.32 (1.00–1.76)
†
More than 15 pack-years 1.55 (1.21–2.00)
‡
Female (n = 3,111)
No pack-years 1.00 (referent)
15 pack-years or fewer 0.85 (0.61–1.14)
More than 15 pack-years 1.55 (1.17–2.05)
‡
Stratiﬁed by Family History
Negative (n = 4,649)
No pack-years 1.00 (referent)
15 pack-years or fewer 1.16 (0.92–1.46)
More than 15 pack-years 1.56 (1.27–1.91
‡)
Positive (n = 746)
No pack-years 1.00 (referent)
15 pack-years or fewer 0.77 (0.4 7–1.26)
More than 15 pack-years 1.50 (0.94–2.38)
a Odds ratios are adjusted for age in all models, and for family history in
thesex-stratiﬁedmodels,andforsexinthefamilyhistory-stratiﬁedmodels.
bFamilyhistorywasdeﬁnedasareporteddiagnosisofcolonorrectalcancer
in a mother, father, sibling, or child of the patient.
†P = .05.
‡P ≤ .001.
We compared the eﬀect of smoking among individuals
with and without a family history, while adjusting for age
and gender. Among patients with no family history, a 15-
or fewer pack-year smoking history did not signiﬁcantly
increase the risk of adenoma. More than 15 pack-years of
smoking increased the odds of adenoma occurrence by 56%
(OR = 1.56; 95% CI 1.27–1.91). For patients with a family
history, smoking did not signiﬁcantly add to the risk of
adenoma, although the higher pack-year group showed a
nonsigniﬁcant trend towards increased risk (OR = 1.50;
95% CI 0.94–2.38). Our formal test of interaction between
smoking and family history did not show signiﬁcance for the
interaction term in the adjusted logistic regression models.
Table 5: An ordered logistic regression model of smoking and
adenoma occurrence among individuals (n = 5,395) undergoing
screening colonoscopy in the New Hampshire Colonscopy Registry
from 2004–2006.
Increasing Size Categorya of
Adenoma v. No Adenoma
b
Variable in full model
c Odds Ratio (95% CI)
Smoking
No pack-years 1.00 (referent)
15 pack-years or fewer 1.10 (0.89–1.34)
More than 15 pack-years 1.61 (1.34–1.93)
∗
Sex
Male 1.00 (referent)
Female 0.54 (0.46–0.63)
∗
Age (years) 1.02 (1.01–1.03)
∗
Family history
d
Negative 1.00 (referent)
Positive 1.69 (1.37–2.08)
∗
aSize categories include <5mm, 5–9mm, ≥1cm; odds ratios represent the
proportional odds for the logit model. Thus, for one unit change in the
predictor variable, the odds for cases in a group less than or equal to a given
size category of polyp are the proportional odds times larger.
bTest for assumption of proportionality of odds across response categories,
using a likelihood ratio test, showed that the assumptions of the ordinal
logistic regression were met (P = .190).
cResults reported are odds ratios for each variable in the model, adjusted
for all other variables included in the model as shown here.
dFamilyhistorywasdeﬁnedasareporteddiagnosisofcolonorrectalcancer
in a mother, father, sibling, or child of the patient.
∗P< . 001.
Thus, we found an additive, but not multiplicative eﬀect
of smoking on adenoma occurrence in the adjusted logistic
regression models stratiﬁed by family history.
In addition to assessing presence or absence of an
adenoma(s) as the outcome variable, we also assessed the
association of smoking history with size of adenomas if
present. Using an ordered logistic regression model we
compared the likelihood of adenoma size (<5mm, 5–9mm,
and ≥1cm versus no adenoma) increasing in relation to
smoking history. We found that, compared to nonsmokers,
the highest-exposure smokers had 61% higher odds for the
presence of an adenoma. The odds continued to increase
proportionally for each successively larger adenoma size
category (OR = 1.61; 95% CI 1.34–1.93) indicating an
association of larger adenoma size with greater smoking
history in addition to simply adenoma occurrence (Table 5).
Positive family history was also signiﬁcantly associated with
larger adenoma size (positive family history: OR = 1.69; 95%
CI 1.37–2.08). Women had lower odds for larger adenomas
(OR = 0.54; 95% CI 0.46–0.63).
4. Discussion
We examined the proportion of patients in a screening
colonoscopy population with multiple key risk factors for
adenomatous polyps. This study extends the work of previ-
ous studies by characterizing the combined inﬂuence of theJournal of Cancer Epidemiology 5
major risk factors: smoking, gender, and family history on
adenoma occurrence.
As in other studies, we found a signiﬁcantly greater
proportion of adenomas among smokers. Pooled risk esti-
mates from a recent meta-analysis of forty-two observational
studies demonstrated a signiﬁcant increase in likelihood of
adenomasassociatedwithsmoking[9].Manyofthesestudies
assessed the risk from smoking on adenoma characteristics,
such as size, location, and number, and others assessed
a host of single risk factors on adenoma occurrence. We
report the combined eﬀect of major risk factors on adenoma
occurrence.
Although many studies have reported a lower risk of
adenomas among women, and a higher risk with smoking,
we additionally examined the joint eﬀect of smoking and
gender. The eﬀect of smoking on adenoma occurrence
seems to be diﬀerent for men and women, with only
males demonstrating an increased risk of adenoma with
lower smoking exposure. Reasons for the diﬀerential eﬀect
of smoking on adenoma occurrence for women are not
known but may be related to hormone replacement therapy,
which was shown to decrease risk of adenomas [12, 13].
Calcium supplementation, which is higher among women,
may also confer a protective eﬀect to oﬀset that of smoking
[14, 15]. Understanding the factors that may be protective
for adenoma initiation in women should be a focus of
investigation.
To our knowledge, we are the ﬁrst to report that while
smoking increases the risk of adenoma in screening patients
with no family history of colorectal cancer or polyps, in the
context of positive family history, the risk was similar for
smokers and nonsmokers, particularly at the lower levels of
smoking exposure. Anderson et al. characterized the eﬀect
of smoking in a screening population and demonstrated that
smoking posed a greater risk than family history for preva-
lence of colorectal neoplasia [8]. Our results demonstrate
that these risk factors in combination with each other do not
exhibit a cumulative increase in risk.
A dominant strength of this study is the ability to
analyze multiple risk factors. Further, we used a large
colonoscopy registry, for which we have reliable measures of
self report, and consistent pathology review. We were able
to diﬀerentiate screening from surveillance colonoscopies,
thereby more closely capturing incident adenomas.
We were somewhat limited in the number of cases for
each risk factor, although this was likely to have limited
only the number of factors upon which we could do
stratiﬁed analyses. Greater numbers of cases would allow
us to perform more detailed subgroup analyses, such as
histological subtypes, adenoma size, colonic site, speciﬁc
covariates, and more reﬁned smoking exposure measures.
Of particular interest would be to examine three- or four-
way associations of smoking and other risk factors with
adenomas.
In conclusion, we report an increased risk of adenomas
and of larger adenomas with smoking, with the inﬂuence
of smoking on adenoma occurrence being greater for men
than women. Patients with no family history should be
counseled about smoking as a signiﬁcantly added risk factor
for adenoma occurrence. For individuals at elevated risk due
to family history, there does not appear to be additional,
cumulative risk conferred by the combination of smoking
and a family history. Further development and expansion
of population-based colonoscopy registries would provide
valuable data resources for more robust analyses, including
detailed risk stratiﬁcation, in order to optimize colorectal
screening practices and reduce the incidence of colorectal
neoplasms.
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